Zacks Investment Research
09 Feb 2026, 18:00 UTC · 35w ago
Impact · against what's priced in
The news for National Health Investors is not material. The article provides generic momentum scores and a short-term price trend that do not represent fundamental shifts or new catalysts.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
National Health Investors (NHI) currently holds a Zacks Rank of #2 (Buy) and a Momentum Style Score of B.
More positive than 69% of claims this week
NHI shares increased by 2.37% over the past week, slightly underperforming its industry group which rose 2.67%.
Continue reading
5 related stories
The stock has seen a 2.37% increase over the last week and maintains a Zacks Rank of #2, suggesting a positive short-term trend.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 48% of claims this week
Which stocks this story touches
More positive than 90% of ticker scores this week
The company has a Zacks Rank of #2 (Buy) and a Momentum Style Score of B, indicating it is a solid momentum pick.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
17h ago
−21.2%
Price is moving against the score
$66.28 vs $84.07 close before publication (Feb 6) · not market-adjusted
NHI chart →
